Evidence map›Paper›PMID 37370845›Full record

ReviewCancers2023

Bibliometric Analysis of Global Research on Tumor Dormancy.

Yuzhe Zhang, Lirong Yan, Zhongqing Wang, Fang Li, Jinqi Lv, Jiaqing Liu, Xuqin Liu, Li Bao, Ye Zhang

Abstract readReview
In one paragraph

Review in Cancers, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Review
  5. Article
  6. Article
  7. An overview of current research on cancer stem cells: a bibliometric analysis.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2024
    Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Yuzhe ZhangThe First Laboratory of Cancer Institute, The First Hospital of China Medical University, Shenyang 110001, China.
Lirong YanThe First Laboratory of Cancer Institute, The First Hospital of China Medical University, Shenyang 110001, China.
Zhongqing WangDepartment of Information Center, The First Hospital of China Medical University, Shenyang 110001, China.ORCID 0000-0002-5330-7538
Fang LiThe First Laboratory of Cancer Institute, The First Hospital of China Medical University, Shenyang 110001, China.
Jinqi LvThe First Laboratory of Cancer Institute, The First Hospital of China Medical University, Shenyang 110001, China.
Jiaqing LiuThe First Laboratory of Cancer Institute, The First Hospital of China Medical University, Shenyang 110001, China.
Xuqin LiuThe First Laboratory of Cancer Institute, The First Hospital of China Medical University, Shenyang 110001, China.
Li BaoThe First Laboratory of Cancer Institute, The First Hospital of China Medical University, Shenyang 110001, China.
Ye ZhangThe First Laboratory of Cancer Institute, The First Hospital of China Medical University, Shenyang 110001, China.

Funding

National Natural Science Foundation of China No. 82073244
6 · The paper itself

Abstract

Tumor dormancy continues to be a research hotspot with numerous pressing problems that need to be solved. The goal of this study is to perform a bibliometric analysis of pertinent articles published in the twenty-first century. We concentrate on significant keywords, nations, authors, affiliations, journals, and literature in the field of tumor dormancy, which will help researchers to review the results that have been achieved and better understand the directions of future research. We retrieved research articles on tumor dormancy from the Web of Science Core Collection. This study made use of the visualization tools VOSviewer, CiteSpace, and Scimago Graphica, as visualization helps us to uncover the intrinsic connections between information. Research on tumor dormancy has been growing in the 21st century, especially from 2015 to the present. The United States is a leader in many aspects of this research area, such as in the number of publications, the number of partners, the most productive institutions, and the authors working in this field. Harvard University is the institution with the highest number of publications, and Aguirre-Ghiso, Julio A. is the author with the highest number of publications and citations. The keywords that emerged after 2017 were "early dissemination", "inhibition", "mechanism", "bone metastasis", and "promotion". We believe that research on tumor dormancy mechanisms and therapy has been, and will continue to be, a major area of interest. The exploration of the tumor dormancy microenvironment and immunotherapeutic treatments for tumor dormancy is likely to represent the most popular future research topics.

Indexed as

bibliometricimmunotherapeutic treatmentsmechanismmicroenvironmenttumor dormancy

Identifiers

PMID37370845
PMCPMC10296974

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.